Clinically-relevant evidence supporting a role for GLP-1 in promoting hippocampal-dependent memory comes from studies using peripheral administration of FDA-approved GLP-1-based diabetes and obesity drugs. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.